Cornillie F - Search Results

1

Danger, high voltage! Using EEG and EOG measurements for cognitive overload detection in a simulated industrial context.

Morton J, Zheleva A, Van Acker BB, Durnez W, Vanneste P, Larmuseau C, De Bruyne J, Raes A, Cornillie F, Saldien J, De Marez L, Bombeke K. Morton J, et al. Among authors: cornillie f. Appl Ergon. 2022 Jul;102:103763. doi: 10.1016/j.apergo.2022.103763. Epub 2022 Apr 8. Appl Ergon. 2022. PMID: 35405457

2

A Multidimensional IRT Approach for Dynamically Monitoring Ability Growth in Computerized Practice Environments.

Park JY, Cornillie F, van der Maas HLJ, Van Den Noortgate W. Park JY, et al. Among authors: cornillie f. Front Psychol. 2019 Mar 29;10:620. doi: 10.3389/fpsyg.2019.00620. eCollection 2019. Front Psychol. 2019. PMID: 30984068 Free PMC article.

3

Comparing the prediction performance of item response theory and machine learning methods on item responses for educational assessments.

Park JY, Dedja K, Pliakos K, Kim J, Joo S, Cornillie F, Vens C, Van den Noortgate W. Park JY, et al. Among authors: cornillie f. Behav Res Methods. 2023 Jun;55(4):2109-2124. doi: 10.3758/s13428-022-01910-8. Epub 2022 Jul 11. Behav Res Methods. 2023. PMID: 35819719 Free PMC article.

4

An explanatory item response theory method for alleviating the cold-start problem in adaptive learning environments.

Park JY, Joo SH, Cornillie F, van der Maas HLJ, Van den Noortgate W. Park JY, et al. Among authors: cornillie f. Behav Res Methods. 2019 Apr;51(2):895-909. doi: 10.3758/s13428-018-1166-9. Behav Res Methods. 2019. PMID: 30511157

5

Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study.

Ferrante M, Schirbel A, Pierik MJ, Haas T, Flamant M, Khalifa A, Philip G, Cornillie F, Meehan AG, Govoni M. Ferrante M, et al. Among authors: cornillie f. Eur J Gastroenterol Hepatol. 2022 Jun 1;34(6):646-654. doi: 10.1097/MEG.0000000000002374. Epub 2022 Apr 8. Eur J Gastroenterol Hepatol. 2022. PMID: 35412484

6

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review.

Luttropp K, Dozier M, Justo N, Cornillie F, Kachroo S, Govoni M, Salomonsson S, Black CM, Khalifa A. Luttropp K, et al. Among authors: cornillie f. BMJ Open. 2019 May 28;9(5):e027456. doi: 10.1136/bmjopen-2018-027456. BMJ Open. 2019. PMID: 31142529 Free PMC article.

7

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study.

Magro F, Lopes S, Silva M, Coelho R, Portela F, Branquinho D, Correia L, Fernandes S, Cravo M, Caldeira P, Sousa HT, Patita M, Lago P, Ramos J, Afonso J, Redondo I, Machado P, Cornillie F, Lopes J, Carneiro F; Portuguese IBD Group [GEDII]. Magro F, et al. Among authors: cornillie f. J Crohns Colitis. 2019 Oct 28;13(11):1387-1393. doi: 10.1093/ecco-jcc/jjz071. J Crohns Colitis. 2019. PMID: 30989180 Clinical Trial.

8

Early Dose Optimisation of Golimumab in Nonresponders to Induction Treatment for Ulcerative Colitis Is Effective and Supported by Pharmacokinetic Data.

Philip G, Cornillie F, Adedokun JO, Melsheimer R, Rutgeerts P, Colombel JF, Marano C. Philip G, et al. Among authors: cornillie f. J Crohns Colitis. 2019 Sep 27;13(10):1257-1264. doi: 10.1093/ecco-jcc/jjz052. J Crohns Colitis. 2019. PMID: 30847474 Clinical Trial.

9

Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational Study.

Berger AE, Duru G, de Vries A, Marini JC, Aoucheta D, Cornillie F, Nancey S, Detrez I, Gils A, Roblin X, Paul S. Berger AE, et al. Among authors: cornillie f. Ther Drug Monit. 2019 Aug;41(4):459-466. doi: 10.1097/FTD.0000000000000629. Ther Drug Monit. 2019. PMID: 30817702

10

Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional Therapy.

Panés J, Lindsay JO, Teich N, Lindgren S, Colombel JF, Cornillie F, Flynn HA, Huyck S, Stryszak P, Yao R, Philip G, Reinisch W. Panés J, et al. Among authors: cornillie f. J Crohns Colitis. 2019 Sep 19;13(9):1148-1157. doi: 10.1093/ecco-jcc/jjz048. J Crohns Colitis. 2019. PMID: 30809631

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page